PT - JOURNAL ARTICLE AU - Rojas, Juan C. AU - Lyons, Patrick G. AU - Chhikara, Kaveri AU - Chaudhari, Vaishvik AU - Bhavani, Sivasubramanium V. AU - Nour, Muna AU - Buell, Kevin G. AU - Smith, Kevin D. AU - Gao, Catherine A. AU - Amagai, Saki AU - Mao, Chengsheng AU - Luo, Yuan AU - Barker, Anna K AU - Nuppnau, Mark AU - Beck, Haley AU - Baccile, Rachel AU - Hermsen, Michael AU - Liao, Zewei AU - Park-Egan, Brenna AU - Carey, Kyle A AU - XuanHan AU - Hochberg, Chad H AU - Ingraham, Nicholas E AU - Parker, William F TI - A Common Longitudinal Intensive Care Unit data Format (CLIF) to enable multi-institutional federated critical illness research AID - 10.1101/2024.09.04.24313058 DP - 2024 Jan 01 TA - medRxiv PG - 2024.09.04.24313058 4099 - http://medrxiv.org/content/early/2024/09/04/2024.09.04.24313058.short 4100 - http://medrxiv.org/content/early/2024/09/04/2024.09.04.24313058.full AB - Background Critical illness, or acute organ failure requiring life support, threatens over five million American lives annually. Electronic health record (EHR) data are a source of granular information that could generate crucial insights into the nature and optimal treatment of critical illness. However, data management, security, and standardization are barriers to large-scale critical illness EHR studies.Methods A consortium of critical care physicians and data scientists from eight US healthcare systems developed the Common Longitudinal Intensive Care Unit (ICU) data Format (CLIF), an open-source database format that harmonizes a minimum set of ICU Data Elements for use in critical illness research. We created a pipeline to process adult ICU EHR data at each site. After development and iteration, we conducted two proof-of-concept studies with a federated research architecture: 1) an external validation of an in-hospital mortality prediction model for critically ill patients and 2) an assessment of 72-hour temperature trajectories and their association with mechanical ventilation and in-hospital mortality using group-based trajectory models.Results We converted longitudinal data from 94,356 critically ill patients treated in 2020-2021 (mean age 60.6 years [standard deviation 17.2], 30% Black, 7% Hispanic, 45% female) across 8 health systems and 33 hospitals into the CLIF format, The in-hospital mortality prediction model performed well in the health system where it was derived (0.81 AUC, 0.06 Brier score). Performance across CLIF consortium sites varied (AUCs: 0.74-0.83, Brier scores: 0.06-0.01), and demonstrated some degradation in predictive capability. Temperature trajectories were similar across health systems. Hypothermic and hyperthermic-slow-resolver patients consistently had the highest mortality.Conclusions CLIF facilitates efficient, rigorous, and reproducible critical care research. Our federated case studies showcase CLIF’s potential for disease sub-phenotyping and clinical decision-support evaluation. Future applications include pragmatic EHR-based trials, target trial emulations, foundational multi-modal AI models of critical illness, and real-time critical care quality dashboards.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Lyons is supported by NIH/NCI K08CA270383. Dr. Rojas is supported by NIH/NIDA R01DA051464 and the Robert Wood Johnson Foundation and has received consulting fees from Truveta. Dr. Bhavani is supported by NIH/NIGMS K23GM144867. Dr. Buell is supported by an institutional research training grant (NIH/NHLBI T32 HL007605). Dr. Gao is supported by NIH/NHLBI K23HL169815, a Parker B. Francis Opportunity Award, and an American Thoracic Society Unrestricted Grant. Dr. Luo is supported in part by NIH U01TR003528 and R01LM013337. Dr. Hochberg is supported by NIH/NHLBI K23HL169743. Dr. Ingraham is supported by NIH/NHLBI K23HL166783. Dr. Parker is supported by NIH K08HL150291 and R01LM014263 and the Greenwall Foundation. The other authors have no conflicts of interest to disclose.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was reviewed and approved by the Institutional Review Board (IRB) of each participating CLIF consortium site. The ethical approvals for the observational studies of critically ill patients and the Electronic Data Warehouse (EDW) building/quality-checking activities are documented in the accompanying supplement. All data were collected and managed in compliance with HIPAA regulations to ensure patient privacy and data security at each CLIF site. Ethical approval for this work was granted by the following ethics committees/IRBs: The Institutional Review Board of Oregon Health & Science University gave ethical approval for this work (IRB approval number: 00025188). The Institutional Review Board of the University of Minnesota gave ethical approval for this work (IRB approval number: STUDY00014815). The Institutional Review Board of the University of Michigan gave ethical approval for this work (IRB approval number: HUM00144238). The Institutional Review Board of Northwestern Medicine gave ethical approval for this work (IRB approval number: STU00202840). The Institutional Review Board of the University of Chicago gave ethical approval for this work (IRB approval number: IRB20-1823). The Institutional Review Board of Rush University gave ethical approval for this work (IRB approval number: 20082408-IRB01). The Institutional Review Board of The Johns Hopkins Health System Corporation gave ethical approval for this work (IRB approval number: IRB00421735). The Institutional Review Board of Emory University gave ethical approval for this work (IRB approval number: Study 1815).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll aggregate results from the paper and prediction model objects are available online at https://clif-consortium.github.io/website/.While patient row-level data cannot be shared due to patient privacy concerns, the authors will run are available via federated analysis using the CLIF format upon reasonable request.https://clif-consortium.github.io/website/